文献速递心血管MR

慢性主动脉瓣反流中区域性替代性纤维化与弥漫性间质纤维化的预后意义:心脏磁共振研究

Regional Replacement and Diffuse Interstitial Fibrosis in Aortic Regurgitation: Prognostic Implications From Cardiac Magnetic Resonance.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-07-14

本研究纳入177例孤立性慢性主动脉瓣反流患者,采用心脏磁共振T1 mapping及晚期钆增强评估心肌纤维化,发现指数化细胞外容积(iECV)随反流严重程度增加,且与死亡或主动脉瓣置换的复合终点独立相关;反流分数≥30%且iECV≥24 mL/m2者事件率最高。

要点

  • iECV随主动脉瓣反流严重程度增加,且与复合终点独立相关。
  • 反流分数≥30%且iECV≥24 mL/m2提示最高事件风险。
  • 替代性纤维化和ECV与复合终点关联不显著。

核心结论

  • 在心脏磁共振纤维化标志物中,iECV较替代性纤维化或ECV与无主动脉瓣置换生存更密切相关。

研究设计与样本

  • 回顾性队列研究,纳入177例孤立性慢性主动脉瓣反流患者,中位年龄58岁,66%男性,中位随访2.5年。
  • 采用对比增强心脏磁共振行T1 mapping及晚期钆增强,测量ECV和iECV,并量化反流严重程度及左室容积。
  • 排除心肌纤维化混杂病因,纵向随访死亡或主动脉瓣置换复合终点。

关键影像表现/征象

  • iECV随主动脉瓣反流严重程度增加(P < 0.001),而ECV和替代性纤维化无显著变化(P = NS)。
  • Kaplan-Meier分析显示,反流分数≥30%且iECV≥24 mL/m2的患者事件率最高。

诊断标准与关键数值

  • 多因素分析显示iECV与复合终点相关(P = 0.01)。
  • 反流分数≥30%且iECV≥24 mL/m2为高危分层阈值。

临床应用与阅片要点

  • 在慢性主动脉瓣反流患者的心脏磁共振报告中,可关注iECV值,尤其当反流分数≥30%且iECV≥24 mL/m2时提示高风险。
  • 替代性纤维化和ECV在本研究中未显示独立预后价值,阅片时应注意区分其与iECV的预后意义。

局限性

  • 单中心回顾性研究,样本量有限,随访时间较短。
  • 排除心肌纤维化混杂病因,结论可能不适用于合并其他心肌病变的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study used cardiac magnetic resonance (CMR) to assess left ventricular (LV) remodeling in chronic aortic regurgitation (AR) to identify both forms of myocardial fibrosis and examine its association with clinical outcomes.

BACKGROUND: Chronic AR leads to LV remodeling, which is associated with 2 forms of myocardial fibrosis: regional replacement fibrosis that is directly imaged by late gadolinium enhancement (LGE) CMR; and diffuse interstitial fibrosis, which can be inferred by T1 mapping techniques.

METHODS: Patients with chronic AR who were undergoing contrast CMR with T1 mapping for valve assessment from 2011 to 2018 were enrolled. Patients with a confounding etiology of myocardial fibrosis were excluded. In addition to quantification of AR severity and LV volumetrics, LGE and T1 mapping pre- and post-contrast were performed to measure extracellular volume (ECV) and indexed ECV (iECV). Patients were followed up longitudinally to assess for the composite event of death and the need for aortic valve replacement.

RESULTS: A total of 177 patients with isolated chronic AR were included (66% males, median age 58 years [IQR: 47.0-68.0 years]) with a median follow up of 2.5 years (IQR: 1.07-3.56 years). The iECV significantly increased with AR severity (P < 0.001), whereas ECV and replacement fibrosis did not (P = NS). On multivariate analysis, iECV remained associated with the composite event (P = 0.01). On Kaplan-Meier analysis stratified by AR regurgitant fraction (RF) and iECV, patients with AR RF severity ≥30% and iECV ≥24 mL/m2 demonstrated the highest event rate.

CONCLUSIONS: Among CMR biomarkers of fibrosis, iECV was more closely associated than replacement fibrosis or ECV with survival free of aortic valve replacement.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Senapati A, Malahfji M, Debs D, et al. Regional Replacement and Diffuse Interstitial Fibrosis in Aortic Regurgitation: Prognostic Implications From Cardiac Magnetic Resonance. JACC Cardiovasc Imaging. 2021. PMID: 34274265. doi:10.1016/j.jcmg.2021.04.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。